Zobrazeno 1 - 3
of 3
pro vyhledávání: '"G P, Scaperrotta"'
Autor:
S. Di Cosimo, C. Depretto, R. Miceli, P. Baili, S. Ljevar, M. Sant, V. Cappelletti, S. Folli, M. Gennaro, F. G. De Braud, G. Bianchi, A. Vingiani, G. Pruneri, A. Marchianò, E. La Rocca, M. C. De Santis, G. P. Scaperrotta
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:775-781
Autor:
E. La Rocca, M. C. De Santis, M. Silvestri, E. Ortolan, M. Valenti, S. Folli, F. G. de Braud, G. V. Bianchi, G. P. Scaperrotta, G. Apolone, M. G. Daidone, V. Cappelletti, G. Pruneri, S. Di Cosimo
Purpose Physical examinations and annual mammography (minimal follow-up) are as effective as laboratory/imaging tests (intensive follow-up) in detecting breast cancer (BC) recurrence. This statement is now challenged by the availability of new diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112db9785d549050c733edf1a8660c8c
http://hdl.handle.net/11379/561316
http://hdl.handle.net/11379/561316
Autor:
S, Di Cosimo, C, Depretto, R, Miceli, P, Baili, S, Ljevar, M, Sant, V, Cappelletti, S, Folli, M, Gennaro, F G, De Braud, G, Bianchi, A, Vingiani, G, Pruneri, A, Marchianò, E, La Rocca, M C, De Santis, G P, Scaperrotta
Publikováno v:
Journal of cancer research and clinical oncology. 148(4)
Mammographic density (MD) is a risk factor for breast cancer (BC) development, and recurrence. However, its predictive value has been less studied. Herein, we challenged MD as a biomarker associated with response in patients treated with neoadjuvant